Biotech RadarJobs updated

COMPANY

Bracco

HQ: Milano, Italy source · bracco.com ↗

Status: Acquired, now part of Bracco S.p.A. · How status works

Clinical Phase 3

150 open jobs · last seen Oct 23, 2026 · 50 sources

Profile checked Oct 10, 2026

Keywords: Prostate Cancer Coronary Artery Disease Coronary Artery Stenosis Central Nervous System Diseases Central Nervous System Neoplasms Renal Insufficiency Ovarian Cancer Liver Neoplasms Brain Disease Peripheral Arterial Occlusive Disease Radiation Exposure Heart Diseases Hypothyroidism Pancreatic Ductal Adenocarcinoma Steno-occlusive Disease Brain Tumor Gadolinium Retention Heart Disease Aortic Disorders Carotid Disease Pulmonary Disease Peripheral Artery Disease Pulmonary Hypertension Central Nervous System Disease Contrast Induced Nephropathy Chronic Renal Impairment Diabetes Mellitus Brain Lesions Carotid, Aortic, Renal or Peripheral Artery Disease Breast Cancer Moderate to Severe Chronic Kidney Disease Peripheral Vascular Disease Brain Pathology Central Nervous System Pathology Kidney Diseases Pulmonary Embolism BR55

150Open jobs49Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Senior Automation EngineerITA - Ceriano LaghettoOct 21, 2026Oct 21, 2026
Electronic Technician/ Mechatronic (m/w/d)DEU - SingenOct 20, 2026Oct 9, 2026
UPSTREAM MARKETING & BD MANAGER, DIGITAL HEALTHCHN - ShanghaiOct 20, 2026Oct 20, 2026
Electrical & Instrumentation Maintenance Senior SpecialistITA - Ceriano LaghettoOct 19, 2026Oct 19, 2026
Territory Sales Manager - Philadelphia - Bracco Medical Technologies6 locations (listed on the posting)Oct 17, 2026Oct 18, 2026

See all 150 jobs

Trial and FDA signals

Job counts as of Oct 18, 2026. All trial and FDA signals

Timeline

  1. Board tracked Radar started tracking this company’s job board (150 open jobs at last check). source ↗
  2. Trial start Phase 3: Lumason® Infusion vs. Bolus Administrations source ↗
  3. Trial start —: Study With Oral Isovue in Abdominopelvic CT source ↗
  4. Trial start Phase 2: Optimal Timing of BR55 CEUS of the Ovaries source ↗
  5. Trial start Phase 4: Thyroid Function of Pediatric Subjects Following Isovue® Administration source ↗
  6. Trial start Phase 2: BR55 in Characterization of Ovarian Lesions source ↗
  7. Trial start —: Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs source ↗
  8. Trial start Phase 2: Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions source ↗
  9. Trial start —: Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients source ↗
  10. Trial start Phase 4: A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA) source ↗
  11. Trial start Phase 3: Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142 source ↗
  12. Trial start Phase 3: Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography source ↗
  13. Trial start Phase 3: Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141 source ↗
  14. Trial start —: Retrospective Study of MRI in Pediatric Patients source ↗
  15. Trial start —: Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control source ↗
  16. Trial start Phase 1/Phase 2: A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer source ↗
  17. Trial start Phase 4: Crossover Comparison of MultiHance and Dotarem source ↗
  18. Trial start —: Multidetector Computed Tomography (MDCT) Tailored Protocol source ↗
  19. Trial start Phase 4: Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain source ↗
  20. Trial start —: Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning source ↗
  21. Trial start —: Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites source ↗
  22. Trial start Phase 2: Safety of SonoVue on Pulmonary Hemodynamics source ↗
  23. Trial start Phase 4: Kidney Damage in Patients With Normal eGFR source ↗
  24. Trial start Phase 4: Kidney Damage in Patients With Moderate Fall in eGFR source ↗
  25. Trial start Phase 4: Kidney Damage In Patients With Severe Fall In eGFR source ↗

Showing 25 of 50 dated events.

Open jobs 150

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Senior Automation EngineerITA - Ceriano LaghettoOct 21, 2026Oct 21, 2026Not stated
Electronic Technician/ Mechatronic (m/w/d)DEU - SingenOct 20, 2026Oct 9, 2026Entry
UPSTREAM MARKETING & BD MANAGER, DIGITAL HEALTHCHN - ShanghaiOct 20, 2026Oct 20, 2026Not stated
Electrical & Instrumentation Maintenance Senior SpecialistITA - Ceriano LaghettoOct 19, 2026Oct 19, 2026Not stated
Territory Sales Manager - Philadelphia - Bracco Medical Technologies6 locations (listed on the posting)Oct 17, 2026Oct 18, 2026Not stated
Legal Counsel - Blue Earth Diagnostics, Inc.Needham, MAOct 16, 2026Oct 14, 2026Mid
Molecular Imaging Account Manager, Oncology - Michigan - Blue Earth DiagnosticsUSA - Field Based - BEDOct 16, 2026Oct 16, 2026Not stated
Clinical Specialist - Kansas City/Oklahoma City - Bracco Medical Technologies2 locations (listed on the posting)Oct 16, 2026Oct 17, 2026Not stated
Associate Director, Pricing Operations & ContractsNeedham, MAOct 16, 2026Oct 17, 2026Not stated
Warehouse clerkMontreal, CanadaOct 16, 2026Oct 17, 2026Not stated
Material HandlerMontreal, CanadaOct 16, 2026Oct 17, 2026Not stated
Molecular Imaging Account Manager, Oncology - Los Angeles - Blue Earth Diagnostics, Inc.USA - Field Based - BEDOct 15, 2026Oct 9, 2026Mid
Sr. Principal Regulatory Affairs Specialist - Bracco Medical TechnologiesEden Prairie, MNOct 15, 2026Oct 9, 2026Senior
CLINICAL SPECIALISTCHN - ShanghaiOct 15, 2026Oct 15, 2026Mid
Accounts Payable SpecialistPrinceton, NJOct 15, 2026Oct 16, 2026Not stated
Clinical Trial Manager, Oncology - Blue Earth Diagnostics, Inc.Needham, MAOct 14, 2026Oct 9, 2026Mid
Responsabile di Zona (RDZ)Milan, ItalyOct 14, 2026Oct 14, 2026Mid
Account Receivable SpecialistMilan, ItalyOct 13, 2026Oct 13, 2026Mid
CEUS APPLICATION SPECIALISTCHN - ShanghaiOct 13, 2026Oct 13, 2026Mid
Energy Asset & Project ManagerMilan, ItalyOct 13, 2026Oct 14, 2026Mid
Operations Engineer Sterile Production (m/w/d)DEU - SingenOct 13, 2026Oct 14, 2026Mid
Global Director Marketing Communications, Content Strategy & BrandMilan, ItalyOct 12, 2026Oct 12, 2026Senior
Representante Ventas GobiernoMEX - TlalpanOct 12, 2026Oct 13, 2026Mid
Plant Project Engineer - APIITA - Ceriano LaghettoOct 12, 2026Oct 13, 2026Mid
Marketing InternEden Prairie, MNOct 8, 2026Oct 9, 2026Entry
Marketing & Strategy InternEden Prairie, MNOct 8, 2026Oct 9, 2026Entry
FIELD SALES & ACCOUNT MANAGEMENTDEU - KonstanzOct 8, 2026Oct 9, 2026Mid
MEDICAL DEVICE SPECIALIST - ACIST PORTFOLIOCHE - CadempinoOct 8, 2026Oct 9, 2026Mid
MEDICAL INFORMATION SEPCIALISTCHN - Full RemoteOct 8, 2026Oct 9, 2026Mid
Especialista Vendas ClinicasBRA - São PauloOct 7, 2026Oct 9, 2026Mid
Associate Clinical Applications Specialist, Cardiology - Bracco Diagnostics IncUSA - Full Remote - BDIOct 7, 2026Oct 9, 2026Entry
Laboratory Technician Microbiology (m/w/d)DEU - SingenOct 7, 2026Oct 9, 2026Entry
Automation Expert (m/w/d)DEU - SingenOct 7, 2026Oct 9, 2026Senior
Specialist Quality Operations (m/w/d)DEU - SingenOct 7, 2026Oct 9, 2026Mid
FIELD SALES & ACCOUNT MANAGEMENTDEU - KonstanzOct 7, 2026Oct 9, 2026Mid
Clinical Application Specialist, Oncology - Northwest - Blue Earth Diagnostics4 locations, including BED, Field Based, USAOct 5, 2026Oct 9, 2026Mid
Digital Learning & Training InternshipCHE - CadempinoOct 5, 2026Oct 9, 2026Entry
Senior Manager, Global Medical Affairs & Medical Education - Bracco Medical Technologies7 locations (listed on the posting)Oct 2, 2026Oct 9, 2026Senior
Director, Medical Affairs, Oncology -- Blue Earth DiagnosticsNeedham, MAOct 2, 2026Oct 9, 2026Senior
Senior Clinical Marketing Manager - Bracco Medical Technologies6 locations (listed on the posting)Oct 2, 2026Oct 9, 2026Senior
Systems Engineering Co-op/InternEden Prairie, MNSep 30, 2026Oct 9, 2026Entry
Firmware Engineering Co-opPleasanton, CASep 30, 2026Oct 9, 2026Entry
Compliance InternshipMilan, ItalySep 29, 2026Oct 9, 2026Entry
Mechanical Engineer II - Bracco Medical TechnologiesEden Prairie, MNSep 28, 2026Oct 9, 2026Mid
Manager, Software Engineering - Bracco Medical Technologies6 locations (listed on the posting)Sep 25, 2026Oct 9, 2026Senior
Technical Training InternEden Prairie, MNSep 24, 2026Oct 9, 2026Entry
Medical Device Assembler I - Bracco Medical TechnologiesEden Prairie, MNSep 24, 2026Oct 9, 2026Entry
Supply Chain InternEden Prairie, MNSep 24, 2026Oct 9, 2026Entry
Principal Reliability Engineer - Bracco Medical Technologies6 locations (listed on the posting)Sep 24, 2026Oct 9, 2026Senior
Manager, Systems Engineering - Bracco Medical Technologies6 locations (listed on the posting)Sep 24, 2026Oct 9, 2026Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

All 150 jobs →

Clinical trials (lead sponsor) 49

RecordTitlePhaseStatusStartPrimary completion
NCT06400004Lumason® Infusion vs. Bolus AdministrationsPhase 3RecruitingJul 10, 2024May 31, 2026 (estimated)
NCT03779906Thyroid Function of Pediatric Subjects Following Isovue® AdministrationPhase 4TerminatedMar 26, 2019Nov 15, 2021 (actual)
NCT03493464BR55 in Characterization of Ovarian LesionsPhase 2TerminatedDec 13, 2018Apr 15, 2021 (actual)
NCT03486327Transabdominal Ultrasound With BR55 for Characterization of Pancreatic LesionsPhase 2TerminatedJul 19, 2018Nov 13, 2020 (actual)
NCT04248153Optimal Timing of BR55 CEUS of the OvariesPhase 2TerminatedOct 14, 2019Feb 19, 2020 (actual)
NCT01253213BR55 in Prostate Cancer: an Exploratory Clinical TrialEarly phase 1Completed2010-072012-12 (actual)
NCT00415805Renal MRA Crossover Study Comparing Multihance to Another Contrast AgentPhase 3Completed2006-122008-12 (actual)
NCT04453059Study With Oral Isovue in Abdominopelvic CTNot listedCompletedJul 1, 2021Jul 1, 2022 (actual)
NCT02552238Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142Phase 3CompletedOct 12, 2015Jun 22, 2017 (actual)
NCT02522481Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141Phase 3CompletedSep 24, 2015Nov 7, 2017 (actual)
NCT02142608A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate CancerPhase 1/Phase 2Completed2014-082015-07 (actual)
NCT00395863Multihance at 3 Tesla (3T) in Brain TumorsPhase 4Completed2006-112008-02 (actual)
NCT01136876Kidney Damage in Patients With Moderate Fall in eGFRPhase 4Completed2010-112012-11 (actual)
NCT03108378Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With ControlNot listedCompleted2014-102019-12 (actual)
NCT02282163Evaluation of Safety and Efficacy of Lumason in Pediatric EchocardiographyPhase 3Terminated2015-10May 31, 2018 (actual)
NCT03750188Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrsNot listedCompletedNov 1, 2018Sep 17, 2019 (actual)
NCT00829413SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion CharacterizationPhase 3Completed2010-062013-07 (actual)
NCT03147989Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS PatientsNot listedCompletedMay 18, 2017Dec 7, 2017 (actual)
NCT00788697SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion CharacterizationPhase 3Completed2009-092013-07 (actual)
NCT02596048A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)Phase 4Completed2015-12Apr 30, 2017 (actual)
NCT02070380Crossover Comparison of MultiHance and DotaremPhase 4Completed2014-022015-03 (actual)
NCT01306292Safety of SonoVue on Pulmonary HemodynamicsPhase 2Completed2011-042011-11 (actual)
NCT02291822Retrospective Study of MRI in Pediatric PatientsNot listedCompleted2014-112015-12 (actual)
NCT01613417Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the BrainPhase 4Completed2012-082014-04 (actual)
NCT00600951Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney DiseaseNot listedCompleted2008-012013-08 (actual)
NCT00600834Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney DiseaseNot listedCompleted2008-022013-05 (actual)
NCT01136915Kidney Damage In Patients With Severe Fall In eGFRPhase 4Terminated2010-112012-11 (actual)
NCT01137786Kidney Damage in Patients With Normal eGFRPhase 4Completed2010-122012-04 (actual)
NCT01737333Multidetector Computed Tomography (MDCT) Tailored ProtocolNot listedCompleted2012-102013-07 (actual)
NCT01075217Isovue in Peripheral Digital Subtraction Angiography (DSA)Phase 4Completed2010-042011-12 (actual)
NCT00558792Coronary MDCTA With Iopamidol Injection 370Phase 2Completed2007-112010-05 (actual)
NCT00773409Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)Not listedCompleted2008-102012-07 (actual)
NCT01424774Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI ScanningNot listedCompleted2011-092012-04 (actual)
NCT01430975Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical SitesNot listedCompleted2011-092012-03 (actual)
NCT00911027SonoVue Guided Prostate BiopsyPhase 3Terminated2009-022011-03 (actual)
NCT00292487Patients With Renal Impairment Undergoing CTPhase 4Completed2004-112006-02 (actual)
NCT00782639Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic PatientsPhase 4Terminated2009-032009-09 (actual)
NCT00907530Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the BrainPhase 4Completed2009-092011-03 (actual)
NCT01260636Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral ArteriesPhase 3Completed2009-092011-12 (actual)
NCT00740207Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSAPhase 4Completed2008-092009-07 (actual)
NCT00323310Safety and Efficacy of MultiHance in Pediatric PatientsPhase 3Terminated2006-042008-09 (actual)
NCT00486473Multihance Versus Magnevist in Breast MRIPhase 3Completed2007-072009-12 (actual)
NCT00479024Follow-up Study to Previous CARE TrialNot listedCompleted2007-062007-12 (actual)
NCT00408083Crossover Study With MultiHance vs a Comparator for Peripheral MRAPhase 3Completed2006-122008-11 (actual)
NCT00323102A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the BrainPhase 4Completed2006-05Not listed
NCT00411931A Pharmacokinetics Study of MultiHance in Pediatric PatientsPhase 1Completed2006-092007-12 (actual)
NCT00289614Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)Phase 4Completed2006-01Not listed
NCT00351754Detection of Pulmonary Embolism With CECTPhase 4Completed2006-07Not listed
NCT00289029A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac AngiographyPhase 4Completed2005-07Not listed

Connect

See your connections at Bracco on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback